Additional Steroid Dose May Hel... ( Fewer babies have complications witho...)

Additional Steroid Dose May Help Preemies

Date:1/29/2009

Fewer babies have complications, without ill effects, study finds

THURSDAY, Jan. 29 (HealthDay News) -- Giving a second dose of steroids to babies still in the womb can reduce their post-birth respiratory problems and does not seem to affect their growth the way multiple courses can, new research shows.

In babies born before 34 weeks, about 43 percent of those given a second dose of steroids in utero had complications, compared with about 63 percent of the babies given a placebo.

"We saw a 31 percent reduction in overall composite neonatal morbidity. That's highly significant," said study author Dr. James Kurtzman, an associate clinical professor in the division of maternal-fetal medicine in the department of obstetrics and gynecology at the University of California, Irvine.

The real advantage, he added, came from the reduction in respiratory problems. Fewer babies had respiratory distress syndrome, and fewer babies needed mechanical ventilation.

Results of the study were to be presented Jan. 29 at the Society for Maternal-Fetal Medicine's annual meeting in Washington, D.C. The study will also be published in the March edition of the American Journal of Obstetrics and Gynecology.

Kurtzman and his colleague, Dr. Thomas Garite, began the study because they were concerned that some premature babies were missing out on the potential benefits from at least one dose of pre-birth steroids.

When doctors first started giving steroids to mothers who appeared to be going into pre-term labor, they discovered that, for the babies' health, it was best if the steroid dose was given no more than seven days before delivery.

But it's not always easy to tell exactly when a woman will deliver. So, if a woman passed the seven-day mark and still had not delivered, doctors would repeat the steroid dose. However, doctors soon learned that multiple courses of steroids led to growth restric
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. USAID Provides Additional Wildfire Assistance to Greece
2. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
3. Additional Top Tier Institutions Implement Mediwares HCLL(TM) Transfusion Management Software
4. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
5. Virginia Techs Raving First Year Results Lead to Additional High-Tech Antimicrobial Defense from SportCoatings(TM)
6. People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID
7. Using additional biopsy-scoring data may help determine prostate cancer prognosis
8. Castle Connolly Medical Ltd. Partners with DrScore.com to Provide Additional Quality Information About Doctors to Consumers
9. Dynatronics Adds Three Additional Direct Sales Reps
10. ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
11. Aida Granted Additional Anti-Cancer Patent

Post Your Comments:

Related Image:

Additional Steroid Dose May Help Preemies

(Date:5/22/2012)... The number of liver transplants in the United States ... Researchers said one reason for the decline is that ... and many of those livers end up being discarded ... attempt a transplant. Another reason livers are discarded is ... fatty liver disease, which is associated with metabolic syndrome ...

(Date:5/22/2012)... The enforcement of Law 42/2010, which extends the smoking ... in the percentage of smokers (from 40.3% to 35.3%) ... applies to men and women of all ages and ... pioneering study, carried out by the Society of Prevention ... Security professionals) analysed the consumption of tobacco in the ...

(Date:5/22/2012)... (HealthDay News) -- Certain gene variants linked to ... lower urinary tract symptoms, according to a new ... variant might protect against those symptoms, the study ... of Medicine at Northwestern University in Chicago identified ... risk in nearly 2,000 healthy, white men enrolled ...

(Date:5/22/2012)... psychiatrists attend their field,s largest annual meeting each year, ... report overwhelmingly on positive results. , That,s the ... Journal of Clinical Psychopharmacology by two young psychiatrists ... analyzed the presentations given at two recent meetings of ... presented at the 2009 and 2010 APA meetings that ...

(Date:5/22/2012)... have determined the genome sequences of a dozen ... to be resistant to vancomycin, an antibiotic of ... independently in each strain, and identified shared features ... acquire vancomycin resistance and evade human immune defenses. ... is a leading cause of hospital-acquired infections in ...

Breaking Medicine News(10 mins):Health News:U.S. Liver Transplants Declining 2 Health News:5 percent of workers gave up smoking when the anti-tobacco law took effect 2 Health News:Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk 2 Health News:Bias found in mental health drug research presented at major psychiatric meeting 2 Health News:Bias found in mental health drug research presented at major psychiatric meeting 3 Health News:Genomes show how Staph bacteria gain resistance to last-line drug 2

[0] U.S. Liver Transplants Declining [0] 5 percent of workers gave up smoking when the anti-tobacco law took effect [0] Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk [0] Bias found in mental health drug research presented at major psychiatric meeting [0] Genomes show how Staph bacteria gain resistance to last-line drug

... could help experts determine who,s lying and who,s telling ... They say the eyes are a window into the ... now that "microexpressions" -- lightning-fast, almost imperceptible facial expressions ... thinking. , Now, new research suggests that people have ...

... findings show a link between micronutrient supplementation and reduced ... study published in the June 1 issue of The ... assessment and support in tuberculosis therapy, once common before ... integral part of clinical therapy in most low-income countries ...

... SMBL ) will hold its annual meeting of ... at the Teaneck Marriott at Glenpointe, 100,Frank W. Burr ... close of business on April 2, 2008, are entitled ... before the meeting., About Smart Balance Inc., ...

... autism are increasingly turning to sensory integration treatment ... and theyre seeing good results. In 2007, 71 ... treatment used sensory integration methods, and 91 percent ... from Temple University researchers, presented this month at ...

... Load ... Delivery, SAN JOSE, Calif., April 25 A10 ... of plasma,products, vaccines and other biopharmaceuticals, selected and deployed,A10,s ... application,delivery platform for its MyFluVaccine(TM) portal. MyFluVaccine,(TM),delivered by FFF ...

... surgeons need to remove part of the pancreas, performing ... shorter hospital stay and fewer complications, researchers have concluded. ... remove pancreatic tumors and cysts over five years found ... time in the hospital without experiencing more complications such ...

Other Medicine News:Health News:Fleeting Facial Expressions Reveal Deep Secrets 2 Health News:Fleeting Facial Expressions Reveal Deep Secrets 3 Health News:Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence 2 Health News:Autistic mannerisms reduced by sensory treatment 2 Health News:Autistic mannerisms reduced by sensory treatment 3 Health News:FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager 2 Health News:FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager 3

Fleeting Facial Expressions Reveal Deep Secrets Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence Smart Balance Inc. to Hold Annual Meeting of Stockholders on May 21, 2008 Autistic mannerisms reduced by sensory treatment FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager Minimally invasive pancreas surgery leads to fewer complications, study finds

(Date:5/22/2012)... NEW YORK, May 22, 2012 Fox Insurance Company, ... York, NY, announces the confirmation of a judgment in ... pharmacy benefit manager, in excess of $3.3 million, following ... negligence and breach of contract. On May 21, 2012, ... Georgia, Atlanta Division, issued its decision confirming the arbitration ...

(Date:5/22/2012)... MOUNTAIN VIEW, Calif., May 22, 2012 Based ... market, Frost & Sullivan recognizes Labcyte Inc. with ... for its Echo liquid handler. While various liquid ... incorporates the wide range of advantages provided by ... to revolutionize liquid handling, Labcyte developed a platform ...

(Date:5/22/2012)... Conn., May 22, 2012 Valeritas , ... a new, simple disposable device for the delivery ... 2 diabetes, has selected dLife to ... number-one resource and community network for people living ... V-Go Life, a comprehensive diabetes lifestyle management and ...

Breaking Medicine Technology:Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager 2 Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 2 Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 3 Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 4 Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 5 Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 2 Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 3 Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 4 Scripps scientists see the light in bizarre bioluminescent snail 16922 1 Scripps scientists see the light in bizarre bioluminescent snail 16922 2 Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 1 Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 2 Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 3 Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 4 Fighting flu in newborns begins in pregnancy 77841 1 Fighting flu in newborns begins in pregnancy 77841 2

[0] Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager [0] Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market [0] Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device

... JMR-132 could provide a new therapeutic approach for ... CITY, April 17, 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris Inc. ... endocrine therapy and oncology, today presented an,abstract outlining ... antagonist JMR-132 in breast cancer, at the American,Association ...

... previously announced, primary endpoint not met; plausibly,confounded ... ERBITUX,-, NEW YORK, April 16, 2007 /PRNewswire-FirstCall/ ... today,announced detailed results from the EPIC study ... - comparing ERBITUX(R),(Cetuximab) plus irinotecan to irinotecan ...

AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients

... This increased magnification all glass (1.5x) ... details with more ease., The 4 mirror ... for static and dynamic gonioscopy and features ... high magnification to appreciate details previously unattainable ...

Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...

... P2000 Pachymeter [i.e., PalmScan P2000] device ... biometer, which incorporates A-mode pulsed-echo ultrasound,technology, ... accurately measure the corneal thickness (CT) ... PalmScan P2000 includes two software user,interfaces; ...

... A-Scan [i.e., PalmScan A2000] device is intended ... A-mode pulsed-echo ultrasound,technology, and thus may be ... (AL), anterior,chamber depth (ACD), and lens thickness ... is also intended for calculating the optical ...

Medicine Products:

High Mag 4 Mirror Gonio Lens Naked Gold 20 nm - 50 OD PalmScan P2000: Surgical Pachymeter PalmScan A2000: A-Scan

Additional Steroid Dose May Hel...( Fewer babies have complications witho...),Health